Aziyo Biologics to Participate in the Piper 32nd Annual Virtual Healthcare Conference

Rhea-AI Summary

Aziyo Biologics (Nasdaq: AZYO) will participate in the upcoming Piper Virtual Healthcare Conference from December 1-3, 2020. The company specializes in regenerative medicine, focusing on enhancing surgical outcomes for patients with implantable medical devices. A fireside chat will be available the week of November 23, 2020, accessible through the Investors section of their website. Founded in 2015, Aziyo has developed a portfolio of products for cardiovascular, orthopedic, and reconstructive specialties.

News Market Reaction – AZYO

-2.11%

-2.11% Session move

In the trading session that priced this news, AZYO declined 2.11%, reflecting a moderate negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SILVER SPRING, Md., Nov. 17, 2020 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO), a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, today announced the Company will participate in the upcoming Piper Virtual Healthcare Conference.

Dates: Tuesday, December 1-Thursday December 3, 2020
Format: Fireside chat available the week of November 23, 2020
A link to the fireside chat presentation will be available on the “Investors” section of the Company’s website at www.Aziyo.com.        

About Aziyo Biologics
Aziyo Biologics is a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, concentrating on patients receiving implantable medical devices. Since its founding in 2015, the Company has created a portfolio of commercial-stage products used in cardiovascular, orthopedic, and reconstructive specialties. For more information, visit www.Aziyo.com.        

Media:
Courtney Guyer
Aziyo Biologics, Inc.
PR@aziyo.com

Investors:
Leigh Salvo or Caroline Paul
Gilmartin Group
investors@aziyo.com

FAQ

What is the participation date for Aziyo Biologics in the Piper Virtual Healthcare Conference?

Aziyo Biologics will participate in the Piper Virtual Healthcare Conference from December 1-3, 2020.

Where can I find the fireside chat presentation for Aziyo Biologics?

The fireside chat presentation for Aziyo Biologics will be available on their website's Investors section starting the week of November 23, 2020.

What does Aziyo Biologics specialize in?

Aziyo Biologics specializes in regenerative medicine and focuses on improving surgical outcomes for patients receiving implantable medical devices.

When was Aziyo Biologics founded?

Aziyo Biologics was founded in 2015.

What types of specialties does Aziyo Biologics target?

Aziyo Biologics targets cardiovascular, orthopedic, and reconstructive specialties.